U.S. Markets close in 5 hrs 34 mins
  • S&P 500

    3,904.17
    -21.26 (-0.54%)
     
  • Dow 30

    31,896.70
    -65.16 (-0.20%)
     
  • Nasdaq

    13,480.13
    -117.84 (-0.87%)
     
  • Russell 2000

    2,273.35
    -11.03 (-0.48%)
     
  • Crude Oil

    62.93
    -0.29 (-0.46%)
     
  • Gold

    1,772.70
    -25.20 (-1.40%)
     
  • Silver

    27.75
    -0.11 (-0.39%)
     
  • EUR/USD

    1.2234
    +0.0066 (+0.5383%)
     
  • 10-Yr Bond

    1.4600
    +0.0710 (+5.11%)
     
  • Vix

    22.96
    +1.62 (+7.59%)
     
  • GBP/USD

    1.4161
    +0.0020 (+0.1416%)
     
  • USD/JPY

    106.1550
    +0.2730 (+0.2578%)
     
  • BTC-USD

    51,287.43
    +1,742.73 (+3.52%)
     
  • CMC Crypto 200

    1,025.66
    +31.00 (+3.12%)
     
  • FTSE 100

    6,671.53
    +12.56 (+0.19%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

Ra Medical Systems to Participate in the Piper Sandler Virtual Health Care Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in the Piper Sandler 32nd Annual Health Care Conference being held virtually on December 1-3, 2020.

Investors interested in a 1x1 meeting with Ra Medical management during the conference should contact their Piper Sandler representative.

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017 the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201124005247/en/

Contacts

At the Company:
Andrew Jackson
Chief Financial Officer, Ra Medical Systems
760-496-9540
ajackson@ramed.com

Investors:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com